RxDoctor Payments Data

Thomas del Guercio, MD

Pain Medicine · Brooklyn, NYNPI 1699193060

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $14,747 of the $21,838 with a category attached, or 67.5%. 32 manufacturers reported payments, led by Abbott at 29.0% of the total. Reporting peaked in 2024 at $10,769 and has fallen 69.4% since, to $3,295 in 2025. Among pain medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,838in general payments, 2019–2025

Across 367 payments — averaging $59.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$6K
  • Biotronik NRO, Inc.$3K
  • SPR Therapeutics, Inc$2K
  • Spinal Simplicity, LLC$2K
  • Boston Scientific$2K
  • Medtronic$1K
  • plus $7K from 26 others

What the payments were for

  • Grants$940%
  • Travel & lodging$6,99732%
  • Food & beverage$14,74768%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,838 in reported general payments places this provider in the 90th percentile of 503 pain medicine providers in New York.

See all pain medicine providers in New York

Medicare billing

Part B allowed, 2024
$331,227
Medicare patients
435
Services billed
4,606

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl43$1,563
Gabapentin184$1,489
Celecoxib81$845
Morphine Sulfate18$562
Pregabalin55$499
Hydromorphone Hcl20$461
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$354
Tramadol Hcl58$281
Duloxetine Hcl14$203
Diclofenac Sodium15$188
Meloxicam36$157
Methylprednisolone28$156
Amitriptyline Hcl12$136
Tizanidine Hcl14$132
Diazepam13$9

Paid to pharmacies, not to this prescriber.

Other pain medicine in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →